110 related articles for article (PubMed ID: 12461802)
1. Diabetes mellitus after bone marrow transplantation during childhood.
Traggiai C; Stanhope R; Nussey S; Leiper AD
Med Pediatr Oncol; 2003 Feb; 40(2):128-9. PubMed ID: 12461802
[No Abstract] [Full Text] [Related]
2. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
[TBL] [Abstract][Full Text] [Related]
3. Myasthenia gravis post allogeneic bone marrow transplantation revisited.
Koski SL; Mackey JR; Mackey DS
Bone Marrow Transplant; 1998 Aug; 22(4):403-4. PubMed ID: 9722080
[No Abstract] [Full Text] [Related]
4. Acute myeloid leukaemia in patients with trisomy 21.
Collins KJ
J Paediatr Child Health; 1995 Feb; 31(1):57. PubMed ID: 7748694
[No Abstract] [Full Text] [Related]
5. A preparatory regimen of total body irradiation, busulphan and melphalan for allogeneic bone marrow transplantation in childhood high-risk leukemia and lymphoma.
Yoshihara T; Naya M; Tsunamoto K; Hojo M; Hibi S; Morimoto A; Todo S; Imashuku S
Anticancer Res; 2003; 23(2C):1739-42. PubMed ID: 12820450
[TBL] [Abstract][Full Text] [Related]
6. Acute disseminated encephalomyelitis (ADEM) after allogeneic bone marrow transplantation for acute myeloid leukemia.
Tomonari A; Tojo A; Adachi D; Iseki T; Ooi J; Shirafuji N; Tani K; Asano S
Ann Hematol; 2003 Jan; 82(1):37-40. PubMed ID: 12574963
[TBL] [Abstract][Full Text] [Related]
7. Oupatient programs of myeloablative chemotherapy, autologous and allogeneic bone marrow transplantation.
Ruiz Arguelles GJ
Haematologica; 2000 Dec; 85(12):1233-4. PubMed ID: 11114127
[No Abstract] [Full Text] [Related]
8. Evaluation of leukemic contamination in peripheral blood stem cell leukaphereses vs bone marrow after consolidation therapy in acute myeloid leukemia: not a critical factor in outcome?
Melillo L; Specchia G; Ferrara F; Minervini MM; Pastore D; Carella AM
Haematologica; 2003 Jun; 88(6):715-8. PubMed ID: 12801851
[No Abstract] [Full Text] [Related]
9. Secondary cancer after syngeneic bone marrow transplant.
Lipton JH; Messner HA; Dolan SP
Bone Marrow Transplant; 1995 Sep; 16(3):491-2. PubMed ID: 8535328
[No Abstract] [Full Text] [Related]
10. Previous occurrence of life-threatening abdominal infection is not a contraindication to bone marrow transplantation.
Picardi M; Selleri C; De Rosa G; Califano C; Camera A; Rotoli B
Haematologica; 1999 Aug; 84(8):764-5. PubMed ID: 10457424
[No Abstract] [Full Text] [Related]
11. Porokeratosis of Mibelli following bone marrow transplantation.
Alexis AF; Busam K; Myskowski PL
Int J Dermatol; 2006 Apr; 45(4):361-5. PubMed ID: 16650158
[TBL] [Abstract][Full Text] [Related]
12. West Nile virus infection in bone marrow transplant patients.
Robertson KB; Barron MA; Nieto Y
Bone Marrow Transplant; 2004 Nov; 34(9):823-4. PubMed ID: 15361905
[No Abstract] [Full Text] [Related]
13. [Acute myeloid leukemia].
Bol P
Ned Tijdschr Tandheelkd; 2002 Nov; 109(11):463-4. PubMed ID: 12494710
[No Abstract] [Full Text] [Related]
14. Adoptive immunotherapy after bone marrow transplantation in a patient with relapsed acute myeloid leukaemia and severe psoriasis.
Windrum P; Jones FG; McMullin MF
Bone Marrow Transplant; 2004 Aug; 34(3):281-2. PubMed ID: 15156169
[No Abstract] [Full Text] [Related]
15. Graft-versus-host disease of the CNS after allogeneic bone marrow transplantation.
Saad AG; Alyea EP; Wen PY; Degirolami U; Kesari S
J Clin Oncol; 2009 Oct; 27(30):e147-9. PubMed ID: 19667266
[No Abstract] [Full Text] [Related]
16. Therapy-related, donor-derived AML responding to a second allogeneic BMT.
Jacobs JF; Brons PP; Simons A; van der Reijden BA; Hoogerbrugge PM
Bone Marrow Transplant; 2007 Sep; 40(5):499-500. PubMed ID: 17589531
[No Abstract] [Full Text] [Related]
17. Acute neuropathies after peripheral blood stem cell and bone marrow transplantation.
Rabinstein AA; Dispenzieri A; Micallef IN; Inwards DJ; Litzow MR; Wijdicks EF
Muscle Nerve; 2003 Dec; 28(6):733-6. PubMed ID: 14639588
[TBL] [Abstract][Full Text] [Related]
18. Cytoprotection by amifostine during autologous stem cell transplantation for advanced refractory hematologic malignancies.
Gabriel DA; Shea TC; Serody JS; Moore DT; Kirby SL; Harvey D; Krasnov C
Biol Blood Marrow Transplant; 2005 Dec; 11(12):1022-30. PubMed ID: 16338625
[TBL] [Abstract][Full Text] [Related]
19. Cytoreduction with iodine-131-anti-CD33 antibodies before bone marrow transplantation for advanced myeloid leukemias.
Burke JM; Caron PC; Papadopoulos EB; Divgi CR; Sgouros G; Panageas KS; Finn RD; Larson SM; O'Reilly RJ; Scheinberg DA; Jurcic JG
Bone Marrow Transplant; 2003 Sep; 32(6):549-56. PubMed ID: 12953125
[TBL] [Abstract][Full Text] [Related]
20. Graft-versus-tumour effect in refractory metastatic neuroblastoma.
Marabelle A; Paillard C; Tchirkov A; Halle P; Chassagne J; Deméocq F; Kanold J
Bone Marrow Transplant; 2007 Jun; 39(12):809-10. PubMed ID: 17450181
[No Abstract] [Full Text] [Related]
[Next] [New Search]
